Artificial Intelligence tools integrating blood biomarkers and radiomics to define lung cancer risk in computed tomography screening programs

LDCT lung cancer screening reduces mortality but needs better risk stratification and benign nodule management. We propose integrating blood microRNA biomarkers with radiological and immunological features using Artificial Intelligence (AI). This project aims to predict cancer development, identify malignant nodules, and ultimately reduce mortality.